Rifasutenizol

利福特尼唑

Report date: 2025/08/25 09:25:54
NME

Base Information

Drug NameRifasutenizol
Drug Alias Name瑞法舒坦唑TNP-2198
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRNA-directed RNA polymerase inhibitors
TargetsRNA-directed RNA polymerase
Therapy Area/IndicationsSusceptible anaerobic bacteria infectionHelicobacter pylori infectionDiarrhea +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesTennor Therapeutics (Suzhou) Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTenNor Therapeutics IncTennor Therapeutics (Suzhou) Ltd
Inactive CompaniesN/A
Active IndicationsSusceptible anaerobic bacteria infectionHelicobacter pylori infectionDiarrhea +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A